Results 41 to 50 of about 71,266 (230)

Analysis of the Treatment Efficacy in Late Diagnosis of Alport Syndrome in a Child: Clinical Case

open access: yesВопросы современной педиатрии, 2023
Background. Alport syndrome is a systemic, hereditary, progressive disease characterized by ultrastructural changes in the glomerular basement membrane caused by pathogenic variants of type IV collagen genes.
Svetlana Ya. Volgina   +5 more
doaj   +1 more source

Therapies for Chronic Spontaneous Urticaria: Present and Future Developments

open access: yesPharmaceuticals
Chronic spontaneous urticaria (CSU) is a complex dermatological condition characterized by recurrent wheals and/or angioedema lasting for more than six weeks, significantly impairing patients’ quality of life.
Riccardo Asero   +3 more
doaj   +1 more source

Efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Objective To assess the clinical efficacy and safety of cyclosporin, adalimumab and secukinumab in the treatment of nail psoriasis. Methods Ninety-one patients with nail psoriasis from our hospital were randomly divided into cyclosporin group (30 cases),
Zhanhan TANG   +5 more
doaj   +1 more source

Cross-reactivities of cyclosporin G (NVa2 cyclosporin) and metabolites in cyclosporin A immunoassays

open access: yesClinical Chemistry, 1993
Abstract Immunoassays of cyclosporin A (CsA) have been routinely used to measure CsG. We investigated the cross-reactivities of CsG and its metabolites, as well as the proportion CsG constitutes in relation to total drug measured, for six CsG metabolites (GM1, GM9, GM4N, GM1c, GM1c9, GM19) in the following CsA assays: Sandimmune ...
R W, Yatscoff, L J, Langman, D F, LeGatt
openaire   +2 more sources

Cyclosporine: A Review [PDF]

open access: yesJournal of Transplantation, 2012
The discovery and use of cyclosporine since its inception into clinical use in the late 1970s has played a major role in the advancement of transplant medicine. While it has improved rates of acute rejection and early graft survival, data on long-term survival of renal allografts is less convincing.
Dustin Tedesco, Lukas Haragsim
openaire   +3 more sources

Long-Term Efficacy and Safety of 0.1% Cyclosporine A Cationic Emulsion in Advanced Dry Eye Disease: A 24-Month Retrospective Study

open access: yesPharmaceuticals
Background: To evaluate the effectiveness of 0.1% cyclosporine A (CsA) cationic emulsion in managing advanced dry eye disease (DED), based on clinical parameters: Ocular Surface Disease Index (OSDI), best-corrected visual acuity (BCVA), Tear Break-Up ...
Monika Sarnat-Kucharczyk   +2 more
doaj   +1 more source

Open-label non-blinded cohort study on anti-histaminic resistant chronic idiopathic urticaria in Western India

open access: yesIndian Journal of Dermatology, 2022
Introduction: Chronic idiopathic urticaria (CIU) is a chronic relapsing disease with hives for a period of six weeks or more. It has a significant impact on the physical and mental well-being of patients. Aims and Objectives: Open-label non-blinded study
Subramanian Natarajan   +1 more
doaj   +1 more source

Pharmacokinetics of cyclosporin: a microemulsion in children with idiopathic nephrotic syndrome

open access: yesClinics, 2012
OBJECTIVE: We present a prospective study of a microemulsion of cyclosporin to treat idiopathic nephrotic syndrome in ten children with normal renal function who presented cyclosporin trough levels between 50 and 150 ng/ml and achieved complete remission
Luciana dos Santos Henriques   +2 more
doaj   +1 more source

SEVERE FORM OF ATOPIC DERMATITIS AS A THERAPEUTIC CHALLENGE

open access: yesSlovenska pediatrija, 2022
Atopic dermatitis (AD) is the most common chronic inflammatory skin disease of childhood. The disease is characterized by recurrent eczematoid itchy skin lesions caused by a combination of genetic predisposition and environmental factors (1-2).
Janja Golobič, Gašper Markelj
doaj   +1 more source

Preferential Solvation of Cyclosporin in Aqueous Mixtures of Some Polymeric Cosolvents [PDF]

open access: yesImmunoAnalysis
Background: Cyclosporin is a cyclic peptide-drug used as immunosuppressant for the prophylaxisof transplant rejection whose physicochemical properties in mixed aqueous solvent systems isstill not well understood.
María Ángeles Peña   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy